Salvatore Calanna - Concepedia

Author

Salvatore Calanna

University of Catania ORCID

Also Known As

S Calanna, S. Calanna, SALVATORE CALANNA, Salvatore Calanna, Sattar, Naveed

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

University of Catania Novo Nordisk (Denmark)Gentofte Hospital University of Copenhagen Ospedale Garibaldi

About

Salvatore Calanna is an author at University of Catania specializing in health sciences, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	7	7	280
2	Medicine	7	7	280
3	Diabetes	7	7	280
4	Endocrinology	2	2	101
5	Emergency Medicine	1	1	31

Salvatore Calanna

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity John Wilding, Rachel L. Batterham, Salvatore Calanna, New England Journal of Medicine	2021	3.9K
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 Robert F. Kushner, Salvatore Calanna, Melanie J. Davies, Obesity	2020	265
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity Philip N. Newsome, Sven Francque, Stephen A. Harrison, Alimentary Pharmacology & Therapeutics	2019	174
Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss Sean Wharton, Salvatore Calanna, Melanie J. Davies, Diabetes Obesity and Metabolism	2021	140
Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience Bernard Zinman, Steven P. Marso, Erik Christiansen, Diabetes Care	2018	102
Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes Mikkel Christensen, Salvatore Calanna, Jens J. Holst, The Journal of Clinical Endocrinology & Metabolism	2013	95
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia Mikkel Christensen, Asger Lund, Salvatore Calanna, The Journal of Clinical Endocrinology & Metabolism	2017	91
Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial Michael A. Nauck, Thomas Jensen, Carina Rosenkilde, Diabetes Care	2018	87
Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes Mikkel Christensen, Salvatore Calanna, Alexander H. Sparre‐Ulrich, Diabetes Glucagon ResponsesInsulin SignalingMetabolic SyndromeType 1Health Sciences	2014	82
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria Antonino Di Pino, Roberto Scicali, Salvatore Calanna, Diabetes Care	2014	62

Page 1